EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Screening of Antiglaucoma, Antidiabetic, Anti-Alzheimer, and Antioxidant Activities of Astragalus alopecurus Pall—Analysis of Phenolics Profiles by LC-MS/MS

Leyla Güven iD, Adem Erturk, Fatma Demirkaya Miloğlu, Saleh Alwasel, İlhami Gulcin iD

Pharmaceuticals · 28.04.2023 · 16 (5) · 659

DOI: 10.3390/ph16050659 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 28.04.2023. Verfasst von Leyla Güven und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Botany, Faculty of Pharmacy, Ataturk University, 25240 Erzurum, Turkey. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Turkish Academy of Sciences, King Saud University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Astragalus species are traditionally used for diabetes, ulcers, leukemia, wounds, stomachaches, sore throats, abdominal pain, and toothaches. Although the preventive effects of Astragalus species against diseases are known, there is no record of the therapeutic effects of Astragalus alopecurus. In this study, we aimed to evaluate the in vitro antiglaucoma, antidiabetic, anti-Alzheimer’s disease, and antioxidant activities of the methanolic (MEAA) and water (WEAA) extracts of the aerial part of A. alopecurus. Additionally, its phenolic compound profiles were analyzed by liquid chromatography–tandem mass spectrometry (LC–MS/MS). MEAA and WEAA were evaluated for their inhibition ability on α-glycosidase, α-amylase, acetylcholinesterase (AChE), and human carbonic anhydrase II (hCA II) enzymes. The phenolic compounds of MEAA were analyzed by LC-MS/MS. Furthermore, total phenolic and flavonoid contents were determined. In this context, the antioxidant activity was evaluated by 1,1-diphenyl-2-picrylhydrazyl (DPPH), 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS), N,N-dimethyl-p-phenylene diamine (DMPD), ferric reducing antioxidant power (FRAP), cupric ions (Cu2+) reducing antioxidant capacity (CUPRAC), ferric ions (Fe3+) reducing, and ferrous ions (Fe2+) chelating methods. MEAA and WEAA had IC50 values of 9.07 and 2.24 μg/mL for α-glycosidase, 693.15 and 346.58 μg/mL for α-amylase, 1.99 and 2.45 μg/mL for AChE, and 147.7 and 171.7 μg/mL for hCA II. While the total phenolic amounts in MEAA and WEAA were 16.00 and 18.50 μg gallic acid equivalent (GAE)/mg extract, the total flavonoid contents in both extracts were calculated as 66.23 and 33.115 μg quercetin equivalent (QE)/mg, respectively. MEAA and WEAA showed, respectively, variable activities on DPPH radical scavenging (IC50: 99.02 and 115.53 μg/mL), ABTS radical scavenging (IC50: 32.21 and 30.22 µg/mL), DMPD radical scavenging (IC50: 231.05 and 65.22 μg/mL), and Fe2+ chelating (IC50: 46.21 and 33.01 μg/mL). MEAA and WEAA reducing abilities were, respectively, Fe3+ reducing (λ700: 0.308 and 0.284), FRAP (λ593: 0.284 and 0.284), and CUPRAC (λ450: 0.163 and 0.137). A total of 35 phenolics were scanned, and 10 phenolic compounds were determined by LC-MS/MS analysis. LC-MS/MS revealed that MEAA mainly contained isorhamnetin, fumaric acid, and rosmarinic acid derivatives. This is the first report indicating that MEAA and WEAA have α-glycosidase, α-amylase, AChE, hCA II inhibition abilities, and antioxidant activities. These results demonstrate the potential of Astragalus species through antioxidant properties and enzyme inhibitor ability traditionally used in medicine. This work provides the foundation for further research into the establishment of novel therapeutics for diabetes, glaucoma, and Alzheimer’s disease.

Schlagwörter

Stichwörter der Autor:innen

LC-MS/MSacetylcholinesteraseantioxidant activityastragaluscarbonic anhydraseα-amylaseα-glycosidase

Autor:innen und Institutionen

  • Department of Pharmaceutical Botany, Faculty of Pharmacy, Ataturk University, 25240 Erzurum, Turkey.
  • Department of Pharmacy Services, Hınıs Vocational School, Ataturk University, 25600 Erzurum, Turkey.
  • Department of Analytical Chemistry, Faculty of Pharmacy, Ataturk University, 25240 Erzurum, Turkey.
  • Department of Zoology, College of Science, King Saud University, Riyadh 11362, Saudi Arabia.
  • Department of Chemistry, Faculty of Science, Ataturk University, 25240 Erzurum, Turkey.

ORCID-Profile: Leyla Güven, İlhami Gulcin

Förderung

  • Turkish Academy of Sciences
  • King Saud University

Zitieren

APA

Güven, L., Erturk, A., Miloğlu, F. D., Alwasel, S., & Gulcin, İ. (2023). Screening of Antiglaucoma, Antidiabetic, Anti-Alzheimer, and Antioxidant Activities of Astragalus alopecurus Pall—Analysis of Phenolics Profiles by LC-MS/MS. Pharmaceuticals, 16(5), 659. https://doi.org/10.3390/ph16050659

Vancouver

Güven L, Erturk A, Miloğlu FD, Alwasel S, Gulcin İ. Screening of Antiglaucoma, Antidiabetic, Anti-Alzheimer, and Antioxidant Activities of Astragalus alopecurus Pall—Analysis of Phenolics Profiles by LC-MS/MS. Pharmaceuticals. 2023;16(5):659. doi:10.3390/ph16050659

BibTeX
@article{Gven2023,
  author = {Güven, Leyla and Erturk, Adem and Miloğlu, Fatma Demirkaya and Alwasel, Saleh and Gulcin, İlhami},
  title = {Screening of Antiglaucoma, Antidiabetic, Anti-Alzheimer, and Antioxidant Activities of Astragalus alopecurus Pall—Analysis of Phenolics Profiles by LC-MS/MS},
  journal = {Pharmaceuticals},
  year = {2023},
  volume = {16},
  number = {5},
  pages = {659},
  doi = {10.3390/ph16050659}
}
Kostenlos starten →